MarketersMEDIA / Newsroom / Dr. Charlie Ware Releases Latest Double Blind Study for Sickle Cell Disease

Dr. Charlie Ware Releases Latest Double Blind Study for Sickle Cell Disease

Share This Press Release

New study indicates promising potential for natural SCD treatments, published drcharlieware.com

— An estimated 300,000 new cases of sickle cell disease arise each year across the globe according to a recent report from the American Society of Hematology. Based on a write-up for the Public Library of Science, these figures are expected to surge by 30 percent over the next three decades. This comes as no surprise to Dr. Charlie Ware, A.P., who has spent a number of years conducting Clinical research with sickle cell disease and developing treatments for this condition. Most recently, Dr. Ware has released the findings of the latest double blind study on the effectiveness of EvenFlo.

"We conducted numerous clinical trials even before releasing EvenFlo more than six years ago," said spokesperson, Dr. Caroline Ware. "After its release, we arranged for further testing at several domestic and international medical facilities to reinforce its effectiveness. Initially, the product demonstrated 85 percent effectiveness. We're delighted to report these numbers rose to 97 percent with latest Sickle cell research, and no negative side effects were observed or reported."

EvenFlo is a natural supplement developed to aid in managing acute and chronic pain conditions, including sickle cell crises affecting bones, joints, lungs and abdominal areas. Studies show the product may additionally be effective in relieving nerve pain, muscle cramps, fatigue and anemia also associated with SCD. Primary ingredients in the supplement are phytochemicals said to act as anti-inflammatory and vasodilatory agents.

The purpose of this double blind study was to analyze the effectiveness of EvenFlo in reducing the frequency of sickle cell crises among patients and was conducted in conjunction with Dr. Richard Muga, former Director of National Medical Services and current Cabinet Minister of Health of Kenya. Seventy sickle cell disease patients participated in the study. Further information on the latest findings are available via Dr. Charlie Ware's website with full details soon to be presented to medical journals and healthcare professionals on a global scale.

"We're pleased to provide these new findings to our patients and SCD sufferers around the world," concluded Dr. Ware. "This new study is further proof that effective natural solutions for sickle cell disease can serve as alternative or complimentary treatments for this increasingly common condition. We encourage anyone in need of relief from the many symptoms of SCD to contact us to learn more about how we can help where other treatment options may have fallen short of their expectations."

About Dr. Charlie Ware, A.P.:

Dr. Charlie Ware is a Natural Medical Doctor who specializes in pain management, chronic disease and epigenomics/epigenetics. Dr. Ware has developed a wide range of wellness programs fitting a diversity of medical needs and has spent many years researching sickle cell disease. Living with sickle cell trait himself has given Dr. Ware unique passion and insight for caring for those battling this condition.

Contact Info:
Name: Dr Caroline Ware
Email: Send Email
Organization: Dr Charlie Ware AP
Address: 1940 harrison Street suite 300 Hollywood Fl 33020
Phone: 9544585999
Website: http://drcharlieware.com

Source URL: https://marketersmedia.com/dr-charlie-ware-releases-latest-double-blind-study-for-sickle-cell-disease/492927

Source: MarketersMedia

Release ID: 492927

Latest Releases

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).